ABT logo

Abbott Laboratories (ABT) Depreciation and amortization

annual D&A:

$3.22B-$25.00M(-0.77%)
December 31, 2024

Summary

  • As of today (May 29, 2025), ABT annual depreciation & amortization is $3.22 billion, with the most recent change of -$25.00 million (-0.77%) on December 31, 2024.
  • During the last 3 years, ABT annual D&A has fallen by -$320.00 million (-9.04%).
  • ABT annual D&A is now -9.04% below its all-time high of $3.54 billion, reached on December 31, 2021.

Performance

ABT Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTincome statement metrics

quarterly D&A:

$756.00M-$51.00M(-6.32%)
March 1, 2025

Summary

  • As of today (May 29, 2025), ABT quarterly depreciation & amortization is $756.00 million, with the most recent change of -$51.00 million (-6.32%) on March 1, 2025.
  • Over the past year, ABT quarterly D&A has dropped by -$49.00 million (-6.09%).
  • ABT quarterly D&A is now -19.06% below its all-time high of $934.00 million, reached on March 31, 2021.

Performance

ABT quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTincome statement metrics

TTM D&A:

$3.17B-$49.00M(-1.52%)
March 1, 2025

Summary

  • As of today (May 29, 2025), ABT TTM depreciation & amortization is $3.17 billion, with the most recent change of -$49.00 million (-1.52%) on March 1, 2025.
  • Over the past year, ABT TTM D&A has dropped by -$73.00 million (-2.25%).
  • ABT TTM D&A is now -10.43% below its all-time high of $3.54 billion, reached on December 31, 2021.

Performance

ABT TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTincome statement metrics

ABT Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-0.8%-6.1%-2.3%
3 y3 years-9.0%-8.1%-7.5%
5 y5 years+6.8%-8.7%+2.6%

ABT Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-9.0%at low-8.3%at low-7.5%at low
5 y5-year-9.0%+6.8%-19.1%at low-10.4%+2.6%
alltimeall time-9.0%+947.2%-19.1%+777.0%-10.4%+3476.8%

ABT Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$756.00M(-6.3%)
$3.17B(-1.5%)
Dec 2024
$3.22B(-0.8%)
$807.00M(+0.7%)
$3.22B(-0.2%)
Sep 2024
-
$801.00M(-0.5%)
$3.22B(-0.7%)
Jun 2024
-
$805.00M(0.0%)
$3.25B(+0.2%)
Mar 2024
-
$805.00M(-1.0%)
$3.24B(-0.0%)
Dec 2023
$3.24B(-0.7%)
$813.00M(-1.3%)
$3.24B(+0.2%)
Sep 2023
-
$824.00M(+3.0%)
$3.24B(+0.3%)
Jun 2023
-
$800.00M(-0.7%)
$3.23B(-0.7%)
Mar 2023
-
$806.00M(-0.1%)
$3.25B(-0.5%)
Dec 2022
$3.27B(-7.7%)
$807.00M(-1.0%)
$3.27B(-2.3%)
Sep 2022
-
$815.00M(-0.9%)
$3.34B(-0.9%)
Jun 2022
-
$822.00M(-0.1%)
$3.38B(-1.5%)
Mar 2022
-
$823.00M(-6.8%)
$3.43B(-3.1%)
Dec 2021
$3.54B(+6.3%)
$883.00M(+4.3%)
$3.54B(+0.5%)
Sep 2021
-
$847.00M(-3.1%)
$3.52B(+1.1%)
Jun 2021
-
$874.00M(-6.4%)
$3.48B(+1.4%)
Mar 2021
-
$934.00M(+7.9%)
$3.43B(+3.2%)
Dec 2020
$3.33B(+10.4%)
$866.00M(+7.2%)
$3.33B(+3.4%)
Sep 2020
-
$808.00M(-2.1%)
$3.22B(+1.7%)
Jun 2020
-
$825.00M(-0.4%)
$3.16B(+2.4%)
Mar 2020
-
$828.00M(+9.5%)
$3.09B(+2.5%)
Dec 2019
$3.01B(-8.1%)
$756.00M(+0.3%)
$3.01B(-0.2%)
Sep 2019
-
$754.00M(+0.4%)
$3.02B(-1.9%)
Jun 2019
-
$751.00M(-0.3%)
$3.08B(-3.1%)
Mar 2019
-
$753.00M(-1.3%)
$3.18B(-3.0%)
Dec 2018
$3.28B(+8.5%)
$763.00M(-6.2%)
$3.28B(-2.4%)
Sep 2018
-
$813.00M(-4.4%)
$3.36B(+1.7%)
Jun 2018
-
$850.00M(-0.2%)
$3.30B(+6.5%)
Mar 2018
-
$852.00M(+1.1%)
$3.10B(+2.6%)
Dec 2017
$3.02B(+123.3%)
$843.00M(+11.5%)
$3.02B(+21.0%)
Sep 2017
-
$756.00M(+16.7%)
$2.50B(+20.0%)
Jun 2017
-
$648.00M(-16.3%)
$2.08B(+16.9%)
Mar 2017
-
$774.00M(+142.6%)
$1.78B(+31.6%)
Dec 2016
$1.35B(-8.1%)
$319.00M(-6.2%)
$1.35B(-3.4%)
Sep 2016
-
$340.00M(-2.0%)
$1.40B(-3.0%)
Jun 2016
-
$347.00M(0.0%)
$1.44B(-0.3%)
Mar 2016
-
$347.00M(-5.2%)
$1.45B(-1.6%)
Dec 2015
$1.47B(-4.9%)
$366.00M(-4.4%)
$1.47B(-1.9%)
Sep 2015
-
$383.00M(+8.8%)
$1.50B(+1.9%)
Jun 2015
-
$352.00M(-5.1%)
$1.47B(-3.2%)
Mar 2015
-
$371.00M(-6.1%)
$1.52B(-1.7%)
Dec 2014
$1.55B(-9.9%)
$395.00M(+11.3%)
$1.55B(-2.0%)
Sep 2014
-
$355.00M(-11.3%)
$1.58B(-4.9%)
Jun 2014
-
$400.00M(+0.5%)
$1.66B(-2.1%)
Mar 2014
-
$398.00M(-6.6%)
$1.70B(-1.3%)
Dec 2013
$1.72B(-38.2%)
$426.00M(-2.3%)
$1.72B(-8.6%)
Sep 2013
-
$436.00M(0.0%)
$1.88B(-14.7%)
Jun 2013
-
$436.00M(+3.6%)
$2.20B(-10.4%)
Mar 2013
-
$421.00M(-28.3%)
$2.46B(-11.6%)
Dec 2012
$2.78B(-8.6%)
$587.57M(-22.7%)
$2.78B(-2.1%)
Sep 2012
-
$759.73M(+9.9%)
$2.84B(-2.7%)
Jun 2012
-
$691.43M(-7.0%)
$2.92B(-3.9%)
Mar 2012
-
$743.27M(+14.6%)
$3.04B(-0.1%)
Dec 2011
$3.04B(+16.0%)
$648.53M(-22.6%)
$3.04B(-2.0%)
Sep 2011
-
$838.39M(+3.3%)
$3.11B(+5.5%)
Jun 2011
-
$811.41M(+8.8%)
$2.94B(+4.9%)
Mar 2011
-
$745.67M(+5.1%)
$2.81B(+7.0%)
Dec 2010
$2.62B(+25.6%)
$709.58M(+4.8%)
$2.62B(+6.6%)
Sep 2010
-
$677.02M(+0.3%)
$2.46B(+5.9%)
Jun 2010
-
$675.20M(+20.0%)
$2.33B(+6.3%)
Mar 2010
-
$562.50M(+2.8%)
$2.19B(+4.7%)
Dec 2009
$2.09B(+13.6%)
$547.35M(+1.2%)
$2.09B(+6.4%)
Sep 2009
-
$540.71M(+0.6%)
$1.96B(+2.2%)
Jun 2009
-
$537.40M(+15.8%)
$1.92B(+3.9%)
Mar 2009
-
$464.05M(+9.8%)
$1.85B(+0.7%)
Dec 2008
$1.84B(-0.9%)
$422.56M(-15.2%)
$1.84B(-3.2%)
Sep 2008
-
$498.56M(+7.0%)
$1.90B(-0.3%)
Jun 2008
-
$465.86M(+3.1%)
$1.90B(+1.6%)
Mar 2008
-
$451.85M(-6.5%)
$1.87B(+1.0%)
Dec 2007
$1.85B
$483.19M(-4.1%)
$1.85B(+4.0%)
Sep 2007
-
$503.77M(+15.7%)
$1.78B(+7.4%)
DateAnnualQuarterlyTTM
Jun 2007
-
$435.50M(+0.7%)
$1.66B(+2.6%)
Mar 2007
-
$432.42M(+5.2%)
$1.62B(+3.8%)
Dec 2006
$1.56B(+14.7%)
$411.11M(+7.8%)
$1.56B(+4.9%)
Sep 2006
-
$381.44M(-3.1%)
$1.49B(+2.6%)
Jun 2006
-
$393.61M(+5.6%)
$1.45B(+4.4%)
Mar 2006
-
$372.59M(+10.3%)
$1.39B(+2.0%)
Dec 2005
$1.36B(+5.5%)
$337.71M(-1.6%)
$1.36B(+0.3%)
Sep 2005
-
$343.37M(+3.1%)
$1.35B(+2.3%)
Jun 2005
-
$332.98M(-3.5%)
$1.32B(-1.5%)
Mar 2005
-
$344.88M(+3.5%)
$1.34B(+4.3%)
Dec 2004
$1.29B(+14.3%)
$333.36M(+6.6%)
$1.29B(+0.5%)
Sep 2004
-
$312.80M(-11.4%)
$1.28B(+6.2%)
Jun 2004
-
$353.24M(+22.1%)
$1.21B(+9.3%)
Mar 2004
-
$289.30M(-11.4%)
$1.10B(-2.1%)
Dec 2003
$1.13B(+8.0%)
$326.54M(+37.4%)
$1.13B(+18.3%)
Sep 2003
-
$237.66M(-5.2%)
$953.01M(-5.3%)
Jun 2003
-
$250.59M(-19.9%)
$1.01B(-2.5%)
Mar 2003
-
$312.65M(+105.5%)
$1.03B(-1.0%)
Dec 2002
$1.04B(-10.7%)
$152.11M(-47.8%)
$1.04B(-13.8%)
Sep 2002
-
$291.46M(+5.2%)
$1.21B(-1.3%)
Jun 2002
-
$276.93M(-14.3%)
$1.23B(-2.7%)
Mar 2002
-
$323.12M(+1.3%)
$1.26B(+8.0%)
Dec 2001
$1.17B(+41.2%)
$318.89M(+3.6%)
$1.17B(+11.5%)
Sep 2001
-
$307.87M(-1.1%)
$1.05B(+12.3%)
Jun 2001
-
$311.19M(+35.3%)
$932.91M(+5.4%)
Mar 2001
-
$230.07M(+15.7%)
$884.94M(+7.0%)
Dec 2000
$827.43M(-0.1%)
$198.78M(+3.1%)
$827.43M(+0.6%)
Sep 2000
-
$192.88M(-26.7%)
$822.62M(-2.8%)
Jun 2000
-
$263.21M(+52.5%)
$846.27M(+7.3%)
Mar 2000
-
$172.56M(-11.0%)
$788.35M(-4.8%)
Dec 1999
$828.00M(+5.3%)
$193.97M(-10.4%)
$828.00M(-0.2%)
Sep 1999
-
$216.53M(+5.5%)
$829.43M(+2.3%)
Jun 1999
-
$205.29M(-3.3%)
$810.60M(+0.3%)
Mar 1999
-
$212.21M(+8.6%)
$808.01M(+2.7%)
Dec 1998
$786.40M(+7.9%)
$195.40M(-1.2%)
$786.40M(+1.7%)
Sep 1998
-
$197.70M(-2.5%)
$773.10M(-0.1%)
Jun 1998
-
$202.70M(+6.3%)
$773.97M(+4.1%)
Mar 1998
-
$190.60M(+4.7%)
$743.62M(+2.0%)
Dec 1997
$729.10M(+6.3%)
$182.10M(-8.3%)
$729.10M(+0.6%)
Sep 1997
-
$198.56M(+15.2%)
$725.04M(+1.4%)
Jun 1997
-
$172.36M(-2.1%)
$715.24M(+2.3%)
Mar 1997
-
$176.08M(-1.1%)
$698.88M(+1.9%)
Dec 1996
$686.10M(+21.1%)
$178.04M(-5.7%)
$686.10M(+1.6%)
Sep 1996
-
$188.76M(+21.0%)
$674.99M(+7.9%)
Jun 1996
-
$156.00M(-4.5%)
$625.44M(+5.5%)
Mar 1996
-
$163.30M(-2.2%)
$592.64M(+4.6%)
Dec 1995
$566.42M(+11.0%)
$166.93M(+19.9%)
$566.42M(+9.1%)
Sep 1995
-
$139.21M(+13.0%)
$518.95M(+1.7%)
Jun 1995
-
$123.20M(-10.1%)
$510.34M(-1.0%)
Mar 1995
-
$137.08M(+14.8%)
$515.25M(+0.9%)
Dec 1994
$510.50M(+5.5%)
$119.45M(-8.5%)
$510.50M(+2.3%)
Sep 1994
-
$130.60M(+1.9%)
$498.83M(+1.2%)
Jun 1994
-
$128.11M(-3.2%)
$492.93M(-0.8%)
Mar 1994
-
$132.34M(+22.8%)
$497.12M(+2.7%)
Dec 1993
$484.08M(+13.2%)
$107.78M(-13.6%)
$484.08M(+2.4%)
Sep 1993
-
$124.70M(-5.7%)
$472.60M(+2.9%)
Jun 1993
-
$132.30M(+10.9%)
$459.40M(+5.8%)
Mar 1993
-
$119.30M(+23.9%)
$434.20M(+1.5%)
Dec 1992
$427.80M(+12.9%)
$96.30M(-13.6%)
$427.80M(+1.0%)
Sep 1992
-
$111.50M(+4.1%)
$423.40M(+4.3%)
Jun 1992
-
$107.10M(-5.1%)
$406.10M(+2.9%)
Mar 1992
-
$112.90M(+22.9%)
$394.50M(+4.1%)
Dec 1991
$379.00M(+6.5%)
$91.90M(-2.4%)
$379.00M(-0.6%)
Sep 1991
-
$94.20M(-1.4%)
$381.10M(+2.1%)
Jun 1991
-
$95.50M(-2.0%)
$373.10M(+2.3%)
Mar 1991
-
$97.40M(+3.6%)
$364.70M(+2.5%)
Dec 1990
$355.90M(+15.8%)
$94.00M(+9.0%)
$355.90M(+35.9%)
Sep 1990
-
$86.20M(-1.0%)
$261.90M(+49.1%)
Jun 1990
-
$87.10M(-1.7%)
$175.70M(+98.3%)
Mar 1990
-
$88.60M
$88.60M
Dec 1989
$307.30M
-
-

FAQ

  • What is Abbott Laboratories annual depreciation & amortization?
  • What is the all time high annual D&A for Abbott Laboratories?
  • What is Abbott Laboratories annual D&A year-on-year change?
  • What is Abbott Laboratories quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Abbott Laboratories?
  • What is Abbott Laboratories quarterly D&A year-on-year change?
  • What is Abbott Laboratories TTM depreciation & amortization?
  • What is the all time high TTM D&A for Abbott Laboratories?
  • What is Abbott Laboratories TTM D&A year-on-year change?

What is Abbott Laboratories annual depreciation & amortization?

The current annual D&A of ABT is $3.22B

What is the all time high annual D&A for Abbott Laboratories?

Abbott Laboratories all-time high annual depreciation & amortization is $3.54B

What is Abbott Laboratories annual D&A year-on-year change?

Over the past year, ABT annual depreciation & amortization has changed by -$25.00M (-0.77%)

What is Abbott Laboratories quarterly depreciation & amortization?

The current quarterly D&A of ABT is $756.00M

What is the all time high quarterly D&A for Abbott Laboratories?

Abbott Laboratories all-time high quarterly depreciation & amortization is $934.00M

What is Abbott Laboratories quarterly D&A year-on-year change?

Over the past year, ABT quarterly depreciation & amortization has changed by -$49.00M (-6.09%)

What is Abbott Laboratories TTM depreciation & amortization?

The current TTM D&A of ABT is $3.17B

What is the all time high TTM D&A for Abbott Laboratories?

Abbott Laboratories all-time high TTM depreciation & amortization is $3.54B

What is Abbott Laboratories TTM D&A year-on-year change?

Over the past year, ABT TTM depreciation & amortization has changed by -$73.00M (-2.25%)
On this page